Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study

• Flora Stavridi ,

  Contributed equally to this work with: Flora Stavridi, Konstantine T. Kalogeras

  Affiliation Third Department of Medical Oncology, “Hygeia” Hospital, Athens, Greece

  ⨯
• Konstantine T. Kalogeras ,

  Contributed equally to this work with: Flora Stavridi, Konstantine T. Kalogeras

  Affiliations Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece, Translational Research Section, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece

  ⨯
• Kyriaki Pliarchopoulou,

  Affiliation Oncology Section, Second Department of Internal Medicine, “Hippokration” Hospital, Athens, Greece

  ⨯
• Ralph M. Wirtz,

  Affiliation STRATIFYER Molecular Pathology GmbH, Cologne, Germany

  ⨯
• Zoi Alexopoulou,

  Affiliation Department of Biostatistics, Health Data Specialists Ltd, Athens, Greece

  ⨯
• Flora Zagouri,

  Affiliation Department of Clinical Therapeutics, “Alexandra” Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece

  ⨯
• Elke Veltrup,

  Affiliation STRATIFYER Molecular Pathology GmbH, Cologne, Germany

  ⨯
• Eleni Timotheadou,

  Affiliation Department of Medical Oncology, “Papageorgiou” Hospital, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece

  ⨯
• Helen Gogas,

  Affiliation First Department of Medicine, “Laiko” General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece

  ⨯
• Angelos Koutras,

  Affiliation Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, Patras, Greece

  ⨯
• Georgios Lazaridis,

  Affiliation Department of Medical Oncology, “Papageorgiou” Hospital, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece

  ⨯
• Christos Christodoulou,

  Affiliation Second Department of Medical Oncology, “Metropolitan” Hospital, Piraeus, Greece

  ⨯
• George Pentheroudakis,

  Affiliation Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece

  ⨯
• Apostolos Laskarakis,

  Affiliation First Department of Medical Oncology, “Metropolitan” Hospital, Piraeus, Greece

  ⨯
• Petroula Arapantoni-Dadioti,

  Affiliation Department of Pathology, Micromedica Labs, Athens, Greece

  ⨯
• Anna Batistatou,

  Affiliation Department of Pathology, Ioannina University Hospital, Ioannina, Greece

  ⨯
• Maria Sotiropoulou,

  Affiliation Department of Pathology, “Alexandra” Hospital, Athens, Greece

  ⨯
• Gerasimos Aravantinos,

  Affiliation Second Department of Medical Oncology, “Agii Anargiri” Cancer Hospital, Athens, Greece

  ⨯
• Pavlos Papakostas,

  Affiliation Oncology Unit, “Hippokration” Hospital, Athens, Greece

  ⨯
• Paris Kosmidis,

  Affiliation Second Department of Medical Oncology, “Hygeia” Hospital, Athens, Greece

  ⨯
• Dimitrios Pectasides,

  Affiliation Oncology Section, Second Department of Internal Medicine, “Hippokration” Hospital, Athens, Greece

  ⨯
•  [ ... ],
• George Fountzilas

  * E-mail: fountzil@auth.gr

  Affiliations Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece, Aristotle University of Thessaloniki, Thessaloniki, Greece

  ⨯
• [ view all ]
• [ view less ]